Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pandemic Forward: Home Ocrelizumab Infusion
NCT04650321Phase 4Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ocrelizumab in multiple sclerosis (MS), sponsored by University of Colorado Denver. Started Mar 2021; status: recruiting.
02
Drugs
ocrelizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04650321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650321.